Clinical Trial

Imaging Study in Metastatic Clear Cell RCC.

Name: Imaging Study in Metastatic Clear Cell RCC. — clinical trial record (NCT07671417)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This imaging study aims to assess the feasibility, biodistribution, and dosimetry of the imaging agent in Subjects with Metastatic Clear Cell Renal Cell Cancer (RCC).

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-07-17

Trial Details

NCT Number	NCT07671417
Lead Sponsor	RayzeBio, Inc.
Conditions	Metastatic Clear Cell Renal Cell Carcinoma
Enrollment	10 participants
Start Date	2026-06
Primary Completion	2026-12 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-16